Zoetis, the world’s largest animal health company, recorded weaker sales of livestock health products in 2020, with sales of health medicines for cattle weakest of all.
Reporting full-year results this week, Zoetis said sales of animal health medicines for cattle were down 6% in 2020 to just under $1.6bn (€1.3bn).
Zoetis blamed the drop in sales on competition from generic animal medicine producers and tighter vaccine supplies. Sales of animal health medicines for cattle account for 53% of Zoetis’ entire portfolio of livestock medicine sales.
ADVERTISEMENT
For 2020, sales of pet medicines increased 17% to $3.4bn
The remaining sales in its livestock division are products for treating health issues in pigs, poultry, sheep and other animals. Sales of poultry medicines were down 4% in 2020, while medicines for pigs increased by 2%.
In contrast, Zoetis continues to see bumper sales growth for health products for pets and small animals. For 2020, sales of pet medicines increased 17% to $3.4bn (€2.8bn). Overall, Zoetis recorded a 7% increase in full year sales to $6.7bn (€5.6bn) and made profits of almost $2bn (€1.7bn) – up 11% year-on-year.
Register for free to read this story and our free stories.
This content is available to digital subscribers and loyalty code users only. Sign in to your account, use the code or subscribe to get unlimited access.
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
CODE ACCEPTED
You have full access to the site until next Wednesday at 9pm.
CODE NOT VALID
Please try again or contact support.
Zoetis, the world’s largest animal health company, recorded weaker sales of livestock health products in 2020, with sales of health medicines for cattle weakest of all.
Reporting full-year results this week, Zoetis said sales of animal health medicines for cattle were down 6% in 2020 to just under $1.6bn (€1.3bn).
Zoetis blamed the drop in sales on competition from generic animal medicine producers and tighter vaccine supplies. Sales of animal health medicines for cattle account for 53% of Zoetis’ entire portfolio of livestock medicine sales.
For 2020, sales of pet medicines increased 17% to $3.4bn
The remaining sales in its livestock division are products for treating health issues in pigs, poultry, sheep and other animals. Sales of poultry medicines were down 4% in 2020, while medicines for pigs increased by 2%.
In contrast, Zoetis continues to see bumper sales growth for health products for pets and small animals. For 2020, sales of pet medicines increased 17% to $3.4bn (€2.8bn). Overall, Zoetis recorded a 7% increase in full year sales to $6.7bn (€5.6bn) and made profits of almost $2bn (€1.7bn) – up 11% year-on-year.
If you would like to speak to a member of our team, please call us on 01-4199525.
Link sent to your email address
We have sent an email to your address. Please click on the link in this email to reset your password. If you can't find it in your inbox, please check your spam folder. If you can't find the email, please call us on 01-4199525.
ENTER YOUR LOYALTY CODE:
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
SHARING OPTIONS